Barclays Starts Halozyme Therapeutics (HALO) at Overweight

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/19/2026

1. MRNA
2. KLAR
3. KEYS
4. PANW
5. HD
6. SPY
7. MRK
8. NBIS
9. DVLT
10. MRCY

March 8, 2012 7:51 AM EST
Get Alerts HALO Hot Sheet
Price: $107.62 +2.60%

Rating Summary:
    15 Buy, 5 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 13 | Down: 9 | New: 24
Join SI Premium – FREE
Barclays initiates coverage on Halozyme Therapeutics (NASDAQ: HALO) with an Overweight. PT $15.00.

For an analyst ratings summary and ratings history on Halozyme Therapeutics click here. For more ratings news on Halozyme Therapeutics click here.

Shares of Halozyme Therapeutics closed at $11.19 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

New Coverage

Related Entities

Barclays